Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7341.813 (Published 06 April 2002) Cite this as: BMJ 2002;324:813
- Andrew G Renehan, senior research fellow (arenehan{at}picr.man.ac.uk)⇑a,
- Matthias Egger, professor in epidemiology and public health medicineb,
- Mark P Saunders, consultant clinical oncologistc,
- Sarah T O'Dwyer, consultant surgeona
- a Department of Surgery, Christie Hospital NHS Trust, Manchester M20 4BX
- b MRC Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Bristol BS8 2PR
- c Department of Clinical Oncology, Christie Hospital NHS Trust, Manchester
- Correspondence to: A Renehan
- Accepted 7 November 2001
Abstract
Objective: To review the evidence from clinical trials of follow up of patients after curative resection for colorectal cancer.
Design: Systematic review and meta-analysis of randomised controlled trials of intensive compared with control follow up.
Main outcome measures: All cause mortality at five years (primary outcome). Rates of recurrence of intraluminal, local, and metastatic disease and metachronous (second colorectal primary) cancers (secondary outcomes).
Results: Five trials, which included 1342 patients, met the inclusion criteria. Intensive follow up was associated with a reduction in all cause mortality (combined risk ratio 0.81, 95% confidence interval 0.70 to 0.94, P=0.007). The effect was most pronounced in the four extramural detection trials that used computed tomography and frequent measurements of serum carcinoembryonic antigen (risk ratio 0.73, 0.60 to 0.89, P=0.002). Intensive follow up was associated with significantly earlier detection of all recurrences (difference in means 8.5 months, 7.6 to 9.4 months, P<0.001) and an increased detection rate for isolated local recurrences (risk ratio 1.61, 1.12 to 2.32, P=0.011).
Conclusions: Intensive follow up after curative resection for colorectal cancer improves survival. Large trials are required to identify which components of intensive follow up are most beneficial.
What is already known on this topic
What is already known on this topic There is a lack of direct evidence that intensive follow up after initial curative treatment for colorectal cancer leads to increased survival
Guidelines are inconclusive and clinical practice varies widely
What this study adds
What this study adds The cumulative analysis of available data supports the view that intensive follow up after curative resection for colorectal cancer improves survival
If computed tomography and frequent measurements of serum carcinoembryonic antigen are used during follow up mortality related to cancer is reduced by 9-13%
This survival benefit is partly attributable to the earlier detection of all recurrences, particularly the increased detection of isolated recurrent disease
Footnotes
Funding None.
Competing interests None declared.